HIV infection, HAART, and endothelial adhesion molecules: current perspectives. (Q35721900)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15050939%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

review article

1 reference

title

HIV infection, HAART, and endothelial adhesion molecules: current perspectives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15050939%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15050939%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Roberto Cauda

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15050939%20AND%20SRC:MED&resulttype=core&format=json

Katleen de Gaetano Donati

26 December 2019

series ordinal

1

object named as

Katleen de Gaetano Donati

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15050939%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Ricardo Rabagliati

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15050939%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 April 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15050939%20AND%20SRC:MED&resulttype=core&format=json

Lancet Infectious Diseases

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15050939%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15050939%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

213-222

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15050939%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15050939%20AND%20SRC:MED&resulttype=core&format=json

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Coronary heart disease in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Combination antiretroviral therapy and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

HIV infection and cardiovascular disease--is there really a link?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Immune function of vascular endothelial cells is impaired by HIV

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Fundamentals of endothelial function for the clinical cardiologist

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

A reliable marker of endothelial cell dysfunction: does it exist?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Infection and atherosclerosis: emerging mechanistic paradigms

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Endothelial dysfunction: a marker of atherosclerotic risk

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Circulating cell adhesion molecules and death in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Soluble P-selectin and the risk of future cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Inflammatory cell adhesion molecules in ischemic cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

A functional integrin ligand on the surface of platelets: intercellular adhesion molecule-2

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

CD40 ligand--assessing risk instead of damage?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Increased levels of soluble P-selectin in hypercholesterolemic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Plasminogen-activator inhibitor type 1 and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Evidence of prolonged inflammation in unstable angina and non-Q wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Increased soluble form of P-selectin in patients with unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Soluble form of selectins in blood of patients with acute myocardial infarction and coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Serial changes in plasma levels of soluble P-selectin in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Infection of the retina by human immunodeficiency virus type I.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

The effects of HIV infection on endothelial function

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

HIV antigen in the brains of patients with the AIDS dementia complex

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

HIV-1 induction of CD40 on endothelial cells promotes the outgrowth of AIDS-associated B-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

HIV-1 infection induces functional alterations in human liver endothelial cells in primary culture

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Productive HIV-1 infection of human vascular endothelial cells requires cell proliferation and is stimulated by combined treatment with interleukin-1 beta plus tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Productive in vitro infection of human umbilical vein endothelial cells and three colon carcinoma cell lines with HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Interferon gamma stimulates cell-mediated transmission of HIV type 1 from abortively infected endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Host factors in the pathogenesis of HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Haptoglobin polymorphism, iron metabolism and mortality in HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Multifunctional cytokine expression by human coronary endothelium and regulation by monokines and glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

HIV-1 induces tumour necrosis factor and IL-1 gene expression in primary human macrophages independent of productive infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Long-term exposure of human blood vessels to HIV gp120, morphine, and anandamide increases endothelial adhesion of monocytes: uncoupling of nitric oxide release.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

HIV-1 envelope glycoprotein 120 increases intercellular adhesion molecule-1 expression by human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Interactions between endothelial cells and HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Increased levels of serum intercellular adhesion molecule 1 in HIV infection are related to immune activation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Elevated serum levels of circulating intercellular adhesion molecule-1 in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Serum concentrations of soluble intercellular adhesion molecule-1 and progress towards disease in patients infected with HIV

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Increased concentrations of soluble tumor necrosis factor receptor 75 but not of soluble intercellular adhesion molecule-1 are associated with the decline of CD4+ lymphocytes in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Levels of the circulating cell adhesion molecule E-selectin and disease progression in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Abnormal levels of circulating adhesion molecules in HIV-1 infection with characteristic alterations in opportunistic infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Circulating cell adhesion molecules in HIV1-infected patients as indicator markers for AIDS progression

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Premature atherosclerosis in HIV-infected individuals--focus on protease inhibitor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Changes in circulating levels of soluble cell adhesion molecules following highly active antiretroviral treatment of HIV-1-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Increased soluble markers of endothelial dysfunction in HIV-positive patients under highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Association between protease inhibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Coronary artery disease and human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Pathogenesis of HIV-associated cardiovascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Cardiovascular risk factors and antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Thiazolidinediones could improve endothelial dysfunction and risk of premature coronary heart disease in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Sustained benefits of metformin therapy on markers of cardiovascular risk in human immunodeficiency virus-infected patients with fat redistribution and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Bezafibrate-induced improvement in glucose uptake and endothelial function in protease inhibitor-associated insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Effects of statins on inflammation in patients with acute and chronic coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy--potential immunomodulatory effects of antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Pathogenesis of HIV-associated heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900971-5

7 January 2021

10.1016/S1473-3099(04)00971-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15050939%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference